TEPEZZA (teprotumumab)

**Product type:** Human Prescription Drug

**Active ingredient:** TEPROTUMUMAB

**Strength:** 500 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** Horizon Therapeutics USA, Inc.

**Marketing category:** BLA (BLA761143)

**Pharmacologic class:** Insulin-like Growth Factor-1 Receptor Inhibitor [EPC], Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]